Dolby Laboratories AI Stock Analysis
Want to see DLB full AI Analyst Report?
Dolby Laboratories (DLB) AI Stock Analysis
Dolby Laboratories
(NYSE:DLB)
DLB scores well on financial quality (high margins, strong free cash flow, very low leverage) and a constructive earnings outlook driven by upbeat Q4/FY26 guidance and strategic traction (VDP/auto/Atmos-Vision). The score is tempered by premium valuation (P/E ~27) and technical overbought signals (RSI/Stoch), alongside acknowledged timing volatility and uneven recent revenue trends.
Dolby Laboratories Key Performance Indicators (KPIs)
Remaining Performance ObligationsRepresents the value of contracted revenue yet to be recognized, offering insight into future revenue streams and business stability.
RPO jumped sharply in late‑2023 and remained elevated before drifting down through early‑2026, signaling a big wave of licensing recoveries and multi‑period contracts that are now being recognized. Management’s commentary (a large Q2 recovery, expanding OEM/streaming licenses, and growing foundational patents) explains the backlog-driven upside, but the gradual decline warns bookings haven’t consistently replaced recognized revenue—investors should watch new high‑value licensing wins and minimum‑volume commitments to judge whether revenue visibility is becoming sustainably stronger or just timing‑driven.
Dolby Laboratories (DLB) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $5.96B
- Dividend Yield
- 2.26%
- Average Volume (3M)
- 811.87K
- Price to Earnings (P/E)
- 26.7
- Beta (1Y)
- 0.68
- Revenue Growth
- 0.55%
- EPS Growth
- -13.85%
- Country
- US
- Employees
- 2,051
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Software - Application
Dolby Laboratories Business Overview & Revenue Model
Company Description
Dolby Laboratories, Inc. develops pioneering audio and visual technologies designed to enhance entertainment and communication experiences across a broad spectrum of platforms. These include cinematic venues, digital television, various transmission...
How the Company Makes Money
Dolby primarily makes money by licensing its proprietary technologies and collecting royalties tied to the use of Dolby audio and imaging solutions in products and content distribution. A major revenue stream comes from licensing agreements with cons...
Dolby Laboratories Earnings Call Summary
The call conveyed a broadly positive outlook driven by strong Q4 guidance (midpoint implying ~23% YoY growth), strategic momentum in high-growth initiatives (VDP, OptiView, auto, Dolby Atmos/Vision adoption), robust margins (~90% non-GAAP gross margin), healthy cash flow ($167M) and an active capital return program (buybacks and dividend +9%). Key risks include timing-dependency of some revenue (large deals and MVCs), memory cost pressure on mobile/PC that could reduce device volumes, modest declines in foundational audio/PC, and some one-time tax and restructuring impacts. Overall, the positive strategic progress and financial strength outweigh the near-term risks and timing volatility.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management guided Q4 FY26 revenue of $362–392M (licensing $335–365M) with non‑GAAP gross margin ~90%, non‑GAAP operating expenses $195–205M and non‑GAAP EPS $1.13–1.28 (midpoint implies ~23% YoY revenue growth), citing early‑Q4 VDP deals, higher in‑car Dolby Atmos units, wearables and timing of minimum volume commitments as drivers; for FY26 they expect revenue $1.41–1.44B (licensing $1.31–1.34B), non‑GAAP operating expenses $785–795M, non‑GAAP EPS $4.25–4.40 and about a 100‑basis‑point annual non‑GAAP operating margin improvement (up from prior 50–100 bps range), with other revenue up high‑teens (auto, VDP), broadcast up mid‑single digits, mobile up mid‑single digits, CE flattish, PC down low‑single digits, and Dolby Atmos/Dolby Vision/imaging patents revenue roughly +15% YoY; Q3 actuals to date were $305M revenue ($282M licensing, $23M products & services), non‑GAAP EPS $0.69, operating cash flow ~$167M, $65M buybacks (1.2M shares), $0.36 dividend (+9% YoY), and $756M cash & investments.
Dolby Laboratories Financial Statement Overview
Summary
High-quality financial profile: exceptionally strong gross margins (~88% annual/TTM), consistently positive free cash flow (TTM FCF ~$345M), and a very conservative balance sheet with minimal leverage (debt-to-equity ~1.8% TTM). Offsetting this strength, growth has been uneven with a sharp TTM revenue decline and some margin/return moderation versus prior peaks.
Income Statement
72PositiveBalance Sheet
92Very PositiveCash Flow
78Positive| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.35B | 1.35B | 1.27B | 1.30B | 1.25B | 1.28B |
| Gross Profit | 1.19B | 1.19B | 1.13B | 1.15B | 1.11B | 1.15B |
| EBITDA | 372.80M | 378.56M | 399.81M | 345.57M | 318.89M | 450.37M |
| Net Income | 226.18M | 255.02M | 261.82M | 200.66M | 184.09M | 310.23M |
Balance Sheet | ||||||
| Total Assets | 3.16B | 3.23B | 3.13B | 2.99B | 2.70B | 3.12B |
| Cash, Cash Equivalents and Short-Term Investments | 670.05M | 702.60M | 577.75M | 957.11M | 817.58M | 1.27B |
| Total Debt | 47.45M | 38.88M | 46.99M | 50.65M | 50.94M | 72.12M |
| Total Liabilities | 563.89M | 595.81M | 643.72M | 622.38M | 451.15M | 518.66M |
| Stockholders Equity | 2.58B | 2.62B | 2.48B | 2.36B | 2.25B | 2.60B |
Cash Flow | ||||||
| Free Cash Flow | 344.50M | 430.26M | 297.25M | 336.74M | 259.12M | 393.30M |
| Operating Cash Flow | 437.60M | 472.20M | 327.25M | 367.08M | 318.58M | 447.75M |
| Investing Cash Flow | -76.55M | -10.59M | -286.29M | 54.21M | -295.94M | -44.91M |
| Financing Cash Flow | -376.78M | -247.24M | -287.81M | -236.81M | -610.56M | -252.51M |
Dolby Laboratories Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DLB, the sentiment is Positive. The current price of 61.16 is below the 20-day moving average (MA) of 63.40, above the 50-day MA of 60.99, and above the 200-day MA of 59.01, indicating a bullish trend. The MACD of 1.11 indicates Positive momentum. The RSI at 56.00 is Neutral, neither overbought nor oversold. The STOCH value of 61.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DLB.
Dolby Laboratories Risk Analysis
Dolby Laboratories disclosed 11 risk factors in its most recent earnings report. Dolby Laboratories reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksDolby Laboratories Peers Comparison
Overall Rating
DLB76Outperform
IDCC74Outperform
CRNC62Neutral
ADEA60Neutral
XPER53Neutral
SOUN50Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | $5.96B | 26.73 | 8.68% | 2.26% | 0.55% | -13.85% | |
| 74Outperform | $7.43B | 23.62 | 27.05% | 0.99% | -11.99% | -36.74% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 62Neutral | $358.22M | -21.82 | -9.84% | ― | 25.84% | 42.54% | |
| 60Neutral | $1.79B | 15.15 | 24.36% | 1.23% | 22.06% | 57.45% | |
| 53Neutral | $296.33M | -8.91 | -7.66% | ― | 1.15% | -495.69% | |
| 50Neutral | $1.70B | -21.27 | -13.35% | ― | 50.65% | 79.91% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DLB | Dolby Laboratories | 61.16 | -2.33 | -3.67% | |
| IDCC | Interdigital | 274.46 | -58.39 | -17.54% | |
| ADEA | Adeia Inc. | 14.75 | 2.53 | 20.65% | |
| CRNC | Cerence Inc | 7.29 | -0.53 | -6.78% | |
| SOUN | SoundHound AI, Inc Class A | 3.23 | -8.30 | -71.99% | |
| XPER | Xperi Inc | 5.93 | 0.11 | 1.89% |
Dolby Laboratories Corporate Events
Dolby Laboratories Announces New CEO and Leadership Transition
PositiveOn August 27, 2026, Dolby Laboratories announced a leadership transition in which long-time President and Chief Executive Officer Kevin Yeaman retired and technology veteran Marc Whitten was appointed President, Chief Executive Officer and a member o...
Dolby Laboratories Reports Q3 Results, Boosts Share Repurchases
NeutralOn July 30, 2026, Dolby Laboratories reported third-quarter fiscal 2026 revenue of $305 million, down from $316 million a year earlier, with GAAP net income falling to $29 million, or $0.30 per diluted share, versus $46 million, or $0.48 per share, i...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 27, 2026
